The Advanced Handbook of Methods in Evidence Based Healthcare 2001
DOI: 10.4135/9781848608344.n6
|View full text |Cite
|
Sign up to set email alerts
|

Randomised and Non-Randomised Studies: Threats to Internal and External Validity

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
2
0

Year Published

2001
2001
2004
2004

Publication Types

Select...
3

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(2 citation statements)
references
References 0 publications
0
2
0
Order By: Relevance
“…(Many critics of EBP have little problem with this.) Many of those who undertake and develop such approaches know only too well about their hazards and shortfalls and try to address or avoid them, or at least be aware of them: for example, the problems of applying the findings of a trial involving patients with certain characteristics to a patient with a different clinical background (McKee et al 1998), or the advantages of non‐randomised designs over randomised (Reeves et al 1998; Sanderson et al 2001). It also seems likely that all but the most hard‐nosed trialists would acknowledge that clinical efficacy is only one aspect of healthcare delivery.…”
Section: Evidence‐based Nursingmentioning
confidence: 99%
“…(Many critics of EBP have little problem with this.) Many of those who undertake and develop such approaches know only too well about their hazards and shortfalls and try to address or avoid them, or at least be aware of them: for example, the problems of applying the findings of a trial involving patients with certain characteristics to a patient with a different clinical background (McKee et al 1998), or the advantages of non‐randomised designs over randomised (Reeves et al 1998; Sanderson et al 2001). It also seems likely that all but the most hard‐nosed trialists would acknowledge that clinical efficacy is only one aspect of healthcare delivery.…”
Section: Evidence‐based Nursingmentioning
confidence: 99%
“…Many examples exist in which non-randomised studies indicate a substantial "treatment" benefit that is subsequently refuted once all confounding has been eliminated by randomisation. 5 In this paper we will argue that, just as nonrandomised studies may provide unreliable evidence of eVect unless very strict conditions are met, 6 so RCTs that are not "blinded" are also diYcult to interpret. There are many large RCTs evaluating new treatments in cancer or heart disease that are, of necessity, unblinded and hence cannot-by the arguments to follow-provide reliable evidence for a treatment eVect as we understand it.…”
mentioning
confidence: 99%